Image

Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery

Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery

Recruiting
18 years and older
Female
Phase 4

Powered by AI

Overview

The purpose of this study is to determine if there is a difference in opioid requirements at 0-48 hours after scheduled cesarean delivery in patients receiving 150 mcg intrathecal morphine compared to 0.2 mg/kg (maximum 20 mg) intravenous methadone.

Eligibility

Inclusion Criteria:

  • English-speaking
  • Age over 18 years old
  • Scheduled cesarean delivery

Exclusion Criteria:

  • Any contraindication to the administration of a spinal technique for anesthesia
  • History of intolerance or adverse reaction to opioid medications
  • History of chronic pain, opioid use >30 OME/day, or substance use disorder
  • History of obstructive sleep apnea, chronic obstructive pulmonary disease, or respiratory compromise (SpO2 <92% on room air, or has a pre-existing oxygen requirement)
  • History of liver or kidney failure
  • Diagnosis of pre-eclampsia with current pregnancy
  • Depression requiring more than one medication
  • Planned use of CSE technique
  • BMI >50.0 kg/m2
  • ASA status IV, V
  • No prior history of an ECG demonstrating QTc > 440ms
  • Surgical complication requiring conversion to general anesthesia

Study details
    Cesarean Delivery

NCT06826742

Mayo Clinic

14 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.